|
Video: What is a Stock Split?
|
|
Athersys is a biotechnology company that is focused primarily in the field of regenerative medicine. Co.'s MultiStem® (invimestrocel) cell therapy, a patented and proprietary allogeneic stem cell product, is its primary platform product and is in late-stage clinical development. By applying its proprietary MultiStem cell therapy product, Co. provides therapeutic product development programs treating neurological conditions, inflammatory and immune disorders, certain pulmonary conditions, cardiovascular disease and other conditions. Co.'s primary programs are focused in the critical care area, with treatment provided in hospitals often in intensive care situations. According to our ATHX split history records, ATHX has had 1 split. | |
|
ATHX (ATHX) has 1 split in our ATHX split history database. The split for ATHX took place on August 29, 2022. This was a 1 for 25 reverse split, meaning for each 25 shares of ATHX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 40 share position following the split.
When a company such as ATHX conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ATHX split history from start to finish, an original position size of 1000 shares would have turned into 40 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ATHX shares, starting with a $10,000 purchase of ATHX, presented on a split-history-adjusted basis factoring in the complete ATHX split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
10/20/2023 |
|
Start price/share: |
$81.00 |
|
End price/share: |
$0.02 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.98% |
|
Average Annual Total Return: |
-58.05% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$2.47 |
|
Years: |
9.56 |
|
|
|
Date |
Ratio |
08/29/2022 | 1 for 25 |
|
|